Like this article? Keep independent journalism alive. Support HuffPost.
More than 250 House and Senate Democrats filed an amicus brief Tuesday afternoon defending the safety and efficacy of the abortion pill mifepristone following a Fifth Circuit Court ruling that briefly banned the mailing of the drug.
“Allowing that decision to remain in place undermines the science-based statutory framework Congress commands and threatens patient access to reproductive health care,” the amicus brief reads.
“As has been well publicized, many U.S. residents in states where abortion is legal live far from any reproductive health care provider," the brief continues. "Reinstating an in-person dispensing requirement for mifepristone exacerbates an already significant reproductive health crisis by limiting access to the most common method of early abortion.”
Also in the news: Rudy Giuliani Is Breathing On His Own While Hospitalized With Pneumonia, Spokesperson Says
On Friday, the Fifth Circuit Court temporarily banned the mailing of mifepristone, which when combined with another drug accounts for nearly two-thirds of all abortions in the U.S. The Supreme Court granted a stay on Monday that restored access to mifepristone by mail for at least another week.
Read the full amicus brief here.

German (DE)
English (US)
Spanish (ES)
French (FR)
Hindi (IN)
Italian (IT)
Russian (RU) 


















Comments